Royal Bank of Canada’s Kindred Biosciences, Inc. KIN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-9,135
| Closed | -$83K | – | 7496 |
|
2021
Q2 | $83K | Buy |
9,135
+2,795
| +44% | +$25.4K | ﹤0.01% | 5246 |
|
2021
Q1 | $31K | Buy |
6,340
+4,028
| +174% | +$19.7K | ﹤0.01% | 5693 |
|
2020
Q4 | $10K | Buy |
2,312
+2,048
| +776% | +$8.86K | ﹤0.01% | 5847 |
|
2020
Q3 | $1K | Buy |
264
+11
| +4% | +$42 | ﹤0.01% | 6040 |
|
2020
Q2 | $1K | Sell |
253
-111
| -30% | -$439 | ﹤0.01% | 6071 |
|
2020
Q1 | $1K | Sell |
364
-2,652
| -88% | -$7.29K | ﹤0.01% | 6063 |
|
2019
Q4 | $26K | Buy |
3,016
+2,816
| +1,408% | +$24.3K | ﹤0.01% | 5153 |
|
2019
Q3 | $1K | Hold |
200
| – | – | ﹤0.01% | 5910 |
|
2019
Q2 | $2K | Sell |
200
-38
| -16% | -$380 | ﹤0.01% | 5672 |
|
2019
Q1 | $2K | Buy |
238
+38
| +19% | +$319 | ﹤0.01% | 5556 |
|
2018
Q4 | $2K | Sell |
200
-5,793
| -97% | -$57.9K | ﹤0.01% | 5597 |
|
2018
Q3 | $84K | Sell |
5,993
-2,046
| -25% | -$28.7K | ﹤0.01% | 4360 |
|
2018
Q2 | $85K | Buy |
8,039
+8,031
| +100,388% | +$84.9K | ﹤0.01% | 4317 |
|
2018
Q1 | $0 | Buy |
+8
| New | – | ﹤0.01% | 6143 |
|
2017
Q4 | – | Sell |
-2,022
| Closed | -$16K | – | 6192 |
|
2017
Q3 | $16K | Buy |
2,022
+1,905
| +1,628% | +$15.1K | ﹤0.01% | 5332 |
|
2017
Q2 | $1K | Buy |
117
+110
| +1,571% | +$940 | ﹤0.01% | 5713 |
|
2017
Q1 | $0 | Buy |
+7
| New | – | ﹤0.01% | 6047 |
|
2015
Q4 | – | Sell |
-673
| Closed | -$3K | – | 6087 |
|
2015
Q3 | $3K | Sell |
673
-30
| -4% | -$134 | ﹤0.01% | 5724 |
|
2015
Q2 | $4K | Buy |
703
+53
| +8% | +$302 | ﹤0.01% | 5784 |
|
2015
Q1 | $5K | Sell |
650
-500
| -43% | -$3.85K | ﹤0.01% | 5298 |
|
2014
Q4 | $9K | Buy |
1,150
+175
| +18% | +$1.37K | ﹤0.01% | 5065 |
|
2014
Q3 | $9K | Sell |
975
-1,050
| -52% | -$9.69K | ﹤0.01% | 4962 |
|
2014
Q2 | $38K | Buy |
+2,025
| New | +$38K | ﹤0.01% | 4484 |
|